DMX Shares Dimerix Limited

ASX

$0.42 — Prices as of close 2026-10-27

Last in our picks 2026-10-23 — not in the current list; analysis below is from that screen

Phase 3 initiation and defined renal catalyst offer substantial small-cap valuation-reset potential.

Future value: $0.70 (+66.70%) · 6-12 months

Signal breakdown

▸Broker-highlighted ACTON3 Phase 3 milestones create a major sentiment catalyst.

Is DMX a buy right now?

Our screen: BUY (score 2) — Phase 3 initiation and defined renal catalyst offer substantial small-cap valuation-reset potential.

Computed from end-of-day data; not personal advice.

Our track record with DMX

First flagged in our daily picks as BUY on 2026-10-23 at $0.42 — +0% since.

Paper trades from our simulated funds at real end-of-day prices; past results don't predict future returns.

Related Biotech picks

CSL.AXCSL Limited MSB.AXMesoblast Limited IMR.AXImricor Medical System SLD.AXSaluda Medical, Inc.NUZ.AXNeurizon Therapeutics NEU.AXNeuren Pharmaceuticals DXB.AXDimerix Limited NYR.AXNyrada Inc.

Browse: all ASX stocks · Biotech picks · today's movers

General information only (Australia). This is general information, not financial product advice. It doesn't consider your objectives, financial situation or needs — consider its appropriateness and seek licensed advice before acting. Not a recommendation to buy or sell any financial product.

Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.